Does Semaglutide Cause Hair Loss? What the Evidence Shows

Be careful with confident answers in either direction here, because the honest picture is unsettled.

Hair loss is not listed among the common side effects in the trial data for semaglutide, and there's no established mechanism by which it would attack hair follicles. At the same time, a 2025 review examining alopecia and semaglutide found that preliminary evidence suggests an association, while noting that definitive proof is not yet established (Haykal, 2025).

So the accurate statement is narrower than "no, it doesn't": the shedding people report is real, the most plausible explanation is the weight loss rather than the molecule, and researchers are still working it out. Anyone giving you a flat yes or no is ahead of the evidence.

Hair grows in cycles. At any moment most of your follicles are in an active growing phase and a minority are resting. Telogen effluvium is what happens when some physiological stressor pushes an unusually large share of follicles into the resting phase at once. A few months later, they shed together — which is why it looks alarming and sudden.

The classic triggers are well documented and have nothing to do with GLP-1 medications specifically:

• Rapid or substantial weight loss
• Reduced calorie and protein intake
• Nutrient shortfalls, particularly iron and protein
• Major physical stress — illness, surgery, childbirth, high fever
• Significant emotional stress

Two features explain most of the confusion. First, the delay: shedding typically starts two to four months after the trigger, so people connect it to whatever is happening now rather than to the weight loss that began in the spring. Second, it's diffuse — a general thinning across the scalp rather than bald patches.

The reassuring part: telogen effluvium is usually self-limiting. Once the trigger resolves, follicles re-enter their growth phase and hair regrows, though it takes months.

Nothing about this is unique to semaglutide — it happens after bariatric surgery, crash diets, and any rapid weight loss. But GLP-1 medications create the conditions efficiently, for a reason we've written about before: appetite suppression makes it very easy to eat far too little without noticing.

When hunger cues go quiet, people routinely under-eat for weeks. That produces exactly the combination telogen effluvium likes — fast weight loss, low protein, and thin nutrient intake. It's the same pattern behind muscle loss during rapid weight loss, and it's why we argue that under-eating, not over-eating, is the real risk on a GLP-1.

In other words: the medication may be the occasion, but the modifiable cause is usually how you're eating on it.

None of this is a treatment for hair loss, and none of it is a substitute for a physician's assessment. It's the set of things that address the underlying trigger:

• Get enough protein. This is the single most relevant lever. A commonly used evidence-based target is roughly 0.7 to 1 gram per pound of body weight daily (Morton et al., 2018).
• Don't stack a crash diet on top of the medication. The medication is already creating a deficit; adding a steep one compounds the trigger.
• Eat enough overall. Chronic under-eating is the condition to avoid, and it's easy to fall into when appetite is suppressed.
• Ask about nutrient status. Iron and other nutrients can be relevant, but supplementing blindly isn't the answer — that's a conversation with your physician, ideally informed by testing rather than guesswork.
• Give it time. Regrowth is measured in months, not weeks, and it lags the correction.

Some presentations are not telogen effluvium and deserve a proper look:

• Patchy or circular bald spots rather than diffuse thinning
• Shedding that continues well beyond six months, or that doesn't improve after weight loss stabilizes
• Hair loss with other symptoms — fatigue, cold intolerance, skin or nail changes
• A family history of pattern hair loss, which can be unmasked or accelerated by a shedding episode

A physician or dermatologist can distinguish between these; an article can't. If your hair loss is distressing you, that alone is reason enough to have it looked at.

Protocol MD's semaglutide and tirzepatide are physician-prescribed and compounded. Compounded medications are not FDA-approved and are not the same as the brand-name products. A US-licensed physician reviews your history, decides whether treatment is appropriate, and manages it over time — including the parts that aren't about the prescription, like whether you're actually eating enough while taking it.

If you're considering treatment, that's where it starts. If you're already on a GLP-1 and something feels off, our guides on why the scale might have stalled and how much you should actually be eating cover the two issues that come up most.

So, does semaglutide cause hair loss? Almost certainly not directly. What it can do is produce the rapid weight loss and reduced intake that trigger telogen effluvium — a temporary, diffuse shedding that shows up a few months late and usually resolves on its own. The research is still emerging and an association has been reported, so it's worth taking seriously rather than dismissing.

The practical response is unglamorous: eat enough, prioritize protein, don't crash-diet on top of the medication, and get patchy or persistent loss properly evaluated.